Toward that end, he and his colleagues partnered with Clene Nanomedicine, a company developing gold nanocrystals into an orally administered therapeutic agent for neurodegenerative circumstances, such as an experimental therapy named CNM-Au8. Au NPs primarily amassed inside endothelial cells of y